Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Volume 2 Issue 7, July 2006

Editorial

Top of page ⤴

Viewpoint

  • Gene therapy suffers the negative perception of being unsafe, expensive and ultimately inapplicable in clinical practice. In this Viewpoint, the authors discuss the benefits of gene therapy being used to treat rheumatic disease, and the requirements that have to be satisfied in order for this to become a clinical reality.

    • Christopher H Evans
    • Steven C Ghivizzani
    • Paul D Robbins
    Viewpoint
  • Tumor necrosis factor (TNF) inhibitors have proven highly effective in improving the signs and symptoms of rheumatoid arthritis, in inhibiting the progression of joint damage, and improving patients' quality of life. This Viewpoint will discuss the major concern relating to the actual use of TNF inhibitors in the clinic: their relatively high acquisition costs.

    • Arthur Kavanaugh
    Viewpoint
Top of page ⤴

Research Highlight

Top of page ⤴

Practice Point

Top of page ⤴

Review Article

  • Progress in our understanding of fibromyalgia has identified aberrant central pain processing as a key abnormality in affected individuals. This Review describes a multimodal approach to treating this central pain syndrome, using neuroactive drugs that modulate sensory processing, and nonpharmacologic therapies such as exercise and cognitive behavioral therapy.

    • Dina Dadabhoy
    • Daniel J Clauw
    Review Article
  • To achieve goodin vivofunction, engineered cartilage needs to exhibit biological and physical properties similar to those of native articular cartilage. Adult multipotent stem cells are considered the cell type of choice for cartilage tissue engineering; this emerging technology shows high promise for producing transplantable cartilage constructs to improve the function of degenerated joints.

    • Faye H Chen
    • Kathleen T Rousche
    • Rocky S Tuan
    Review Article
  • The pathogenesis of the spondyloarthropathies is thought to relate to interactions between genes, including HLA-B27, bacteria, and innate and acquired immune responses. This Review provides an insight into the validity of the genes–bacteria–immune response paradigm, and explores how interactions between these factors might result in disease.

    • Hill Gaston
    Review Article
Top of page ⤴

Case Study

Top of page ⤴

Corrigendum

Top of page ⤴

Search

Quick links